Teva is dedicated to improving the lives of those affected by migraine, going beyond just alleviating symptoms; we aim to enhance the overall quality of life for patients.
Through innovative therapies and a deep understanding of neurological conditions, we work to provide solutions that address both the immediate pain and the long-term challenges this disorder presents.
Migraine is a condition that many people misunderstand. For instance, migraines are often dismissed as mere headaches. However, they are complex neurological disorders affecting over one billion people globally. The pain is intense and often accompanied by nausea, sensitivity to light and sound, and visual disturbances. These symptoms can be so severe that they disrupt daily life, forcing individuals to miss work, social activities, and other essential aspects of life.
Beyond our medical innovations, Teva offers extensive support to people living with migraines including information for patients and caregivers through platforms like Life Effects. These resources include personal stories, expert advice, and practical tips for migraine help. By sharing real experiences, we aim to empower patients and create a supportive community where they can take control of their health.
Our research and development efforts are focused on discovering new and more effective treatments for migraine. By investing in cutting-edge science and technology, Teva strives to offer hope to patients who have struggled with this debilitating condition for years. This condition is often invisible, which leads to a lack of understanding and support. We recognize that each patient’s experience is unique, and our treatments reflect this understanding, offering solutions that meet individual needs.
Teva’s efforts in migraine are about more than just developing treatments. They are about making a tangible difference in the lives of millions of people around the world. Through ongoing research, patient support, and advocacy, we are dedicated to transforming the landscape of care for challenging health conditions.
NPS-ALL-NP-01528 APRIL 2025